BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37375695)

  • 1. The Mixture of Natural Products SH003 Exerts Anti-Melanoma Effects through the Modulation of PD-L1 in B16F10 Cells.
    Han NR; Park HJ; Ko SG; Moon PD
    Nutrients; 2023 Jun; 15(12):. PubMed ID: 37375695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maltol has anti-cancer effects via modulating PD-L1 signaling pathway in B16F10 cells.
    Han NR; Park HJ; Ko SG; Moon PD
    Front Pharmacol; 2023; 14():1255586. PubMed ID: 37731735
    [No Abstract]   [Full Text] [Related]  

  • 3. The immune-enhancing effects of a mixture of Astragalus membranaceus (Fisch.) Bunge, Angelica gigas Nakai, and Trichosanthes Kirilowii (Maxim.) or its active constituent nodakenin.
    Han NR; Kim KC; Kim JS; Ko SG; Park HJ; Moon PD
    J Ethnopharmacol; 2022 Mar; 285():114893. PubMed ID: 34875347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SH003 induces apoptosis of DU145 prostate cancer cells by inhibiting ERK-involved pathway.
    Choi YJ; Choi YK; Lee KM; Cho SG; Kang SY; Ko SG
    BMC Complement Altern Med; 2016 Dec; 16(1):507. PubMed ID: 27927199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Protective Effect of a Functional Food Consisting of
    Han NR; Park HJ; Ko SG; Moon PD
    Foods; 2023 Jan; 12(2):. PubMed ID: 36673369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stigmasterol Exerts an Anti-Melanoma Property through Down-Regulation of Reactive Oxygen Species and Programmed Cell Death Ligand 1 in Melanoma Cells.
    Han NR; Park HJ; Ko SG; Moon PD
    Antioxidants (Basel); 2024 Mar; 13(3):. PubMed ID: 38539913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SH003‑induced G1 phase cell cycle arrest induces apoptosis in HeLa cervical cancer cells.
    Lee KM; Lee K; Choi YK; Choi YJ; Seo HS; Ko SG
    Mol Med Rep; 2017 Dec; 16(6):8237-8244. PubMed ID: 28944910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed Cell Death Protein Ligand-1 Silencing with Polyethylenimine-Dermatan Sulfate Complex for Dual Inhibition of Melanoma Growth.
    Kwak G; Kim D; Nam GH; Wang SY; Kim IS; Kim SH; Kwon IC; Yeo Y
    ACS Nano; 2017 Oct; 11(10):10135-10146. PubMed ID: 28985469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herbal extract SH003 suppresses tumor growth and metastasis of MDA-MB-231 breast cancer cells by inhibiting STAT3-IL-6 signaling.
    Choi YK; Cho SG; Woo SM; Yun YJ; Park S; Shin YC; Ko SG
    Mediators Inflamm; 2014; 2014():492173. PubMed ID: 24976685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study to evaluate the maximum tolerated dose of the combination of SH003 and docetaxel in patients with solid cancer: A study protocol.
    Cheon C; Ko SG
    Medicine (Baltimore); 2020 Sep; 99(38):e22228. PubMed ID: 32957363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SH003 represses tumor angiogenesis by blocking VEGF binding to VEGFR2.
    Choi HS; Kim MK; Lee K; Lee KM; Choi YK; Shin YC; Cho SG; Ko SG
    Oncotarget; 2016 May; 7(22):32969-79. PubMed ID: 27105528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects.
    Xu L; Zhang Y; Tian K; Chen X; Zhang R; Mu X; Wu Y; Wang D; Wang S; Liu F; Wang T; Zhang J; Liu S; Zhang Y; Tu C; Liu H
    J Exp Clin Cancer Res; 2018 Oct; 37(1):261. PubMed ID: 30373602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SH003 selectively induces p73‑dependent apoptosis in triple‑negative breast cancer cells.
    Choi EK; Kim SM; Hong SW; Moon JH; Shin JS; Kim JH; Hwang IY; Jung SA; Lee DH; Lee EY; Lee S; Kim H; Kim D; Kim YS; Choi YK; Kim HI; Choi HS; Cho SG; Kim JE; Kim KP; Hong YS; Lee WK; Lee JS; Kim TW; Ko SG; Jin DH
    Mol Med Rep; 2016 Oct; 14(4):3955-60. PubMed ID: 27599791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma.
    Chen X; Wang K; Jiang S; Sun H; Che X; Zhang M; He J; Wen Y; Liao M; Li X; Zhou X; Song J; Ren X; Yi W; Yang J; Chen X; Yin M; Cheng Y
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35347072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Immunomodulatory Gallotanin-Rich Fraction From
    Lasso P; Gomez-Cadena A; Urueña C; Donda A; Martinez-Usatorre A; Romero P; Barreto A; Fiorentino S
    Front Immunol; 2020; 11():584959. PubMed ID: 33312174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SH003 suppresses breast cancer growth by accumulating p62 in autolysosomes.
    Choi YK; Cho SG; Choi YJ; Yun YJ; Lee KM; Lee K; Yoo HH; Shin YC; Ko SG
    Oncotarget; 2017 Oct; 8(51):88386-88400. PubMed ID: 29179443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylseleninic acid overcomes programmed death-ligand 1-mediated resistance of prostate cancer and lung cancer.
    Hu W; Ma Y; Zhao C; Yin S; Hu H
    Mol Carcinog; 2021 Nov; 60(11):746-757. PubMed ID: 34411338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of xCT suppresses the efficacy of anti-PD-1/L1 melanoma treatment through exosomal PD-L1-induced macrophage M2 polarization.
    Liu N; Zhang J; Yin M; Liu H; Zhang X; Li J; Yan B; Guo Y; Zhou J; Tao J; Hu S; Chen X; Peng C
    Mol Ther; 2021 Jul; 29(7):2321-2334. PubMed ID: 33744468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Antitumor Activity of SH003 and Docetaxel via EGFR Signaling Inhibition in Non-Small Cell Lung Cancer.
    Jeong MS; Lee KW; Choi YJ; Kim YG; Hwang HH; Lee SY; Jung SE; Park SA; Lee JH; Joo YJ; Cho SG; Ko SG
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State of the Art and Future Implications of SH003: Acting as a Therapeutic Anticancer Agent.
    Lee K; Youn BY; Choi YJ; Moon S; Im J; Cho K; Ko SG; Cheon C
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.